REPLIMUNE GROUP INC (REPL) Stock News

USA - NASDAQ:REPL - US76029N1063 - Common Stock

4.16 USD

-0.17 (-3.93%)

Last: 9/24/2025, 8:00:01 PM

4.13 USD

-0.03 (-0.72%)

Pre-Market: 9/25/2025, 7:06:39 AM

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

REPL Latest News, Press Relases and Analysis

All

Press Releases

7 days ago - By: Chartmill - Mentions: PBM GV EDUC WHLR ...

News Image

Let's take a look at the stocks that are in motion in today's session.

7 days ago - By: Chartmill - Mentions: GV INTC WHLR ADAP ...

News Image

Here are the top movers in Thursday's session.

2 days ago - By: Pomerantz LLP

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Replimune Group, Inc. of Class Action Lawsuit and Upcoming Deadlines - REPL

3 days ago - By: Faruqi & Faruqi, LLP

FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Replimune

3 days ago - By: THE ROSEN LAW FIRM, P. A.

REPL Deadline: REPL Investors with Losses in Excess of $100K Have Opportunity to Lead Replimune Group, Inc. Securities Lawsuit Filed by The Rosen Law Firm

3 days ago - By: Bragar Eagel & Squire

REPLIMUNE FINAL DEADLINE ALERT: Bragar Eagel & Squire, P.C. Urges Replimune Group, Inc. Investors to Contact the Firm Regarding Class Action Lawsuit

4 days ago - By: Faruqi & Faruqi LLP

SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Replimune

5 days ago - By: The Rosen Law Firm, P.A.

REPL Deadline: Rosen Law Firm Encourages Replimune Group, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important September 22 Deadline in Securities Class Action First Filed by the Firm – REPL

5 days ago - By: Hagens Berman Sobol Shapiro LLP

Replimune (REPL) Shares Tank 45% After Company Says No Pathway Identified For Lead Drug RP1, Securities Class Action Pending - Hagens Berman

6 days ago - By: The Motley Fool - Mentions: JPM

Why Replimune Stock Was Tumbling Again Today

6 days ago - By: Bragar Eagel & Squire

REPLIMUNE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Replimune Group, Inc. and Encourages Investors to Contact the Firm Before September 22nd

6 days ago - By: Levi & Korsinsky, LLP

Shareholders that lost money on Replimune Group, Inc.(REPL) should contact Levi & Korsinsky about pending Class Action - REPL

6 days ago - By: Benzinga - Mentions: UPS ETNB

This United Parcel Service Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Friday

7 days ago - By: The Motley Fool - Mentions: BMY

Why Replimune Stock Plummeted by Almost 40% Today

7 days ago - By: Faruqi & Faruqi, LLP

Faruqi & Faruqi Reminds Replimune Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 22, 2025 - REPL

7 days ago - By: Hagens Berman Sobol Shapiro LLP

Replimune (REPL) Shares Tank 45% After Company Says No Pathway Identified For Lead Drug RP1, Securities Class Action Pending - Hagens Berman

7 days ago - By: Benzinga - Mentions: PBM SLRX CURX ADAP ...

12 Health Care Stocks Moving In Thursday's Intraday Session

7 days ago - By: Stocktwits - Mentions: IWMW AVUS

News Image

Replimune Stock Plunged 42% Today – Here’s Why

7 days ago - By: Chartmill - Mentions: PBM GV EDUC INTC ...

News Image

Traders are paying attention to the gapping stocks in Thursday's session.

7 days ago - By: Bernstein Liebhard LLP

REPLIMUNE GROUP, INC. (NASDAQ: REPL) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds Replimune Group, Inc. Investors of Upcoming Deadline

7 days ago - By: Replimune, Inc.

Replimune Provides Update Following Type A Meeting with FDA

7 days ago - By: Replimune, Inc.

News Image

Replimune Provides Update Following Type A Meeting with FDA

7 days ago - By: The Gross Law Firm

Replimune Group, Inc. Securities Fraud Class Action Lawsuit Pending: Contact The Gross Law Firm Before September 22, 2025 to Discuss Your Rights - REPL

7 days ago - By: Faruqi & Faruqi LLP

DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Replimune

8 days ago - By: Bragar Eagel & Squire

REPLIMUNE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Replimune Group, Inc. and Encourages Investors to Contact the Firm Before September 22nd

9 days ago - By: Hagens Berman Sobol Shapiro LLP

REPL 6-DAY DEADLINE ALERT: Investor Lawsuit Targets Replimune (REPL) After FDA Deems RP1 Trial Inadequate - Hagens Berman

9 days ago - By: Levi & Korsinsky, LLP

Replimune Group, Inc. Class Action: Levi & Korsinsky Reminds Replimune Group, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 22, 2025 - REPL

9 days ago - By: THE ROSEN LAW FIRM, P. A.

REPL Deadline: REPL Investors with Losses in Excess of $100K Have Opportunity to Lead Replimune Group, Inc. Securities Lawsuit Filed by The Rosen Law Firm